United States — Food and Drug Administration & The Schall Law Firm

United States — Food and Drug Administration: The United States — Food and Drug Administration issued safety warnings concerning serious neurological complications in dogs related to Zoetis' Bedinvetmab, contributing to its weakening adoption.

The Schall Law Firm: The Schall Law Firm is a shareholder rights litigation firm that reminds investors of a class action lawsuit against Zoetis for securities law violations.

United States — Food and Drug Administration: The United States — Food and Drug Administration's delayed clearance for Caris Life Sciences' TriNav Advance product is a key factor contributing to the company's financial issues and the subsequent investor investigations.

The Schall Law Firm: The Schall Law Firm is investigating claims on behalf of investors of Caris Life Sciences for violations of securities laws due to misleading statements and undisclosed information.

United States — Food and Drug Administration: The United States — Food and Drug Administration is the regulatory body that Oculis will not pursue a filing with for its drug candidate OCS-01, following the failed clinical trials.

The Schall Law Firm: The Schall Law Firm is investigating Oculis for violations of securities laws, specifically focusing on whether the company issued false or misleading statements regarding its Phase 3 DIAMOND trials. The firm is encouraging affected shareholders to participate in the investigation.